Mantle cell lymphoma: open trials in Spain

20 open trials have a site in Spain. Registry data; only the trial team decides who can take part.

NCT06084936
A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
Trial Treatment · Phase 3 · Hoffmann-La Roche
Complejo Hospitalario Universitario A Coruña (CHUAC), A Coruña · Hospital Universitari Vall d'Hebron, Barcelona · Hospital Clinic de Barcelona, Barcelona · Hospital Universitario Puerta del Mar, Cadiz · Hospital General Universitario J.M Morales Meseguer, Murcia
Registry updated 2026-11-05
NCT07101328
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Trial Treatment · Phase 1 · Eli Lilly and Company
Institut Catala d'Oncologia - L'Hospitalet, Barcelona · Hospital Universitario Vall d'Hebron, Barcelona · South Texas Accelerated Research Therapeutics (START) Madrid - Hospital Fundacion Jimenez Diaz, Madrid
Registry updated 2026-11-04
2025-521152-34-00
A study to evaluate acalabrutinib, in combination with the R-CHOP standard of care, for previously untreated mantle cell lymphoma in Spain.
Trial Treatment · Phase 2 · Astrazeneca Farmaceutica Spain S.A.
Complexo Hospitalario Universitario A Coruña, A Coruña · Hospital Universitario Fundación Alcorcón, Alcorcón · Institut Catala d'Oncologia, Badalona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital Clinic de Barcelona, Barcelona · Hospital Universitario De Burgos, Burgos · Hospital Universitario Donostia, Donostia · Hospital Universitario de Cabueñes, Gijón · Hospital Universitario de la Princesa, Madrid · Hospital Ruber Juan Bravo, Madrid · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Universitario La Paz, Madrid · Hospital Universitario Regional de Málaga, Málaga · Hospital Son Llatzer, Palma · Hospital Universitario De Salamanca, Salamanca · Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife · Hospital Universitario Marqués de Valdecilla, Santander · University Hospital Virgen Del Rocio S.L., Sevilla · Hospital General Universitario de Valencia, Valencia · Hospital Universitario Dr. Peset Aleixandre, Valencia · Complexo Hospitalario Universitario De Vigo, Vigo
Registry updated 2026-11-03
NCT05365659
IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas
Trial Treatment · Phase 1 · Iksuda Therapeutics Ltd.
Institut Catala D'Oncologia, Badalona · Hospital Universitario Quirónsalud Madrid, Madrid · Hospital Clinico Universitario de Salamanca, Salamanca
Registry updated 2026-11-03
NCT07691606
A Study of ARC-02 in B-cell NHL
Trial Treatment · Phase 1 · Taiho Oncology, Inc.
Hospital Universitari Vall d'Hebron, Barcelona · Hospital San Pedro De Alcántara, Cáceres · Hospital Universitario HM Sanchinarro, Madrid · Hospital Universitario Fundación Jiménez Díaz, Madrid · University Hospital Virgen Del Rocio S.L., Sevilla
Registry updated 2026-11-02
NCT06742996
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
Trial Treatment · Phase 3 · BeOne Medicines
Hospital Clinic de Barcelona, Barcelona · Institut Catala D'oncologia, L'Hospitalet de Llobregat · Hospital Universitario Fundación Jiménez Díaz, Madrid · Hospital Universitario Puerta de Hierro de Majadahonda, Majadahonda
Registry updated 2026-10-29
NCT06564038
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
Trial Treatment · Phase 1/2 · AstraZeneca
Hospital Clinic de Barcelona, Barcelona · Hospital Universitario Ramón y Cajal, Madrid · Hospital Universitario Fundación Jiménez Díaz, Madrid · University Hospital Son Espases, Palma · Complexo Hospitalario Universitario De Santiago, Santiago de Compostela · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-10-28
NCT07029737
A Study to Evaluate Acalabrutinib, in Combination With the R-CHOP Standard of Care, for Previously Untreated Mantle Cell Lymphoma in Spain
Trial Treatment · Phase 2 · AstraZeneca
A Coruña · Alcorcón · Badalona · Barcelona · Burgos · Donostia / San Sebastian · Gijón · Madrid · Majadahonda · Málaga · Palma de Mallorca · Salamanca · Santa Cruz de Tenerife · Santander · Seville · Valencia · Vigo
Registry updated 2026-10-27
NCT06697184
A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.
Trial Treatment · Phase 1/2 · BeOne Medicines
Institut Catala D'oncologia, L'Hospitalet de Llobregat · Hospital General Universitario Gregorio Marañón, Madrid · Complejo Asistencial Universitario de Salamanca, Salamanca
Registry updated 2026-10-26
NCT05006716
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
Trial Treatment · Phase 1/2 · BeOne Medicines
Hospital Universitario Vall Dhebron, Barcelona · Hospital Universitario La Paz, Madrid · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Universitario Fundación Jiménez Díaz, Madrid · Md Anderson Cancer Center Madrid Spain, Madrid · Hospital Universitario Puerta de Hierro - Majadahonda, Majadahonda · Hospital Clinico Universitario de Valencia, Valencia
Registry updated 2026-10-05
2024-512922-27-00
PIRTOBRUTINIB AND GLOFITAMAB IN MANTLE CELL LYMPHOMA
Trial Treatment · Phase 2 · Klinikum der Universitaet Muenchen AöR
Hospital General Universitario Dr. Balmis, Alicante · Institut Catala d'Oncologia, Badalona · Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca, Barcelona · Hospital Universitario Virgen de las Nieves, Granada · Hospital Universitario de la Princesa, Madrid · Hospital Universitario Marqués de Valdecilla, Santander · University Hospital Virgen Del Rocio S.L., Sevilla
Registry updated 2026-09-30
NCT06542250
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
Trial Treatment · Phase 1/2 · AstraZeneca
Barcelona · L'Hospitalet de Llobregat · Madrid
Registry updated 2026-09-30
2023-503206-37-00
A Study to Compare the Efficacy and Safety of Glofitamab as a Single Agent Versus Investigator’s Choice in Patients with Relapsed/Refractory Mantle Cell Lymphoma
Trial Treatment · Phase 3 · F. Hoffmann-La Roche AG
Complexo Hospitalario Universitario A Coruña, A Coruña · Hospital Clinic de Barcelona, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitario Puerta del Mar, Cadiz · Hospital General Universitario Morales Meseguer, Murcia
Registry updated 2026-09-09
NCT06980116
Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies
Trial Treatment · Phase 1 · Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.
Hospital Universitario HM Sanchinarro, Madrid · Hospital Universitario Fundación Jiménez Díaz, Madrid · MD Anderson Cancer Center, Madrid · Hospital Beata María Ana, Madrid · Clínica Universidad de navarra, Pamplona
Registry updated 2026-08-13
NCT05131022
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Trial Treatment · Phase 1 · Nurix Therapeutics, Inc.
Hospital Clinic de Barcelona, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitario de Cabueñes, Gijón · Hospital Ramón y Cajal, Madrid · Hospital Fundación Jimenez Díaz - START Madrid, Madrid
Registry updated 2026-07-02
NCT05544019
Study of SGR-1505 in Mature B-Cell Neoplasms
Trial Treatment · Phase 1 · Schrödinger, Inc.
Institut Catala D'oncologia, L'Hospitalet de Llobregat · Hospital Universitario HM Sanchinarro, Madrid · Clinica Universidad de Navarra, Madrid · Hospital Universitario Fundación Jiménez Díaz, Madrid · Clínica Universidad de navarra, Pamplona · Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcón · Hospital Universitario De Salamanca, Salamanca
Registry updated 2026-02-13
NCT07285590
Clinical Trial to Evaluate the Efficacy and Safety of Pirtobrutinib With Rituximab in Patients With Mantle Cell Lymphoma
Trial Treatment · Phase 2 · Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Institut Català d Oncologia (ICO) - Hospital Germans Trias i Pujol, Badalona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital Clinic de Barcelona, Barcelona · Hospital Clínico Universitario Virgen de la Arrixaca, El Palmar · Institut Català d'oncologia de L'Hospitalet (ICO-L'Hospitalet), L'Hospitalet de Llobregat · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Ramón y Cajal, Madrid · Hospital Universitario 12 de Octubre, Madrid · Clínica Universidad Navarra, Madrid · Hospital Costa del Sol, Marbella · Clinica Universidad Navarra, Pamplona · Hospital Universitario De Salamanca, Salamanca · Hospital Universitario Y Politecnico La Fe, Valencia · Hospital Clínico de Valencia, Valencia
Registry updated 2025-12-16
2024-519790-19-00
IMMUNOTHERAPY WITH DIFFERENTIATED T CELLS, ADULTS, AUTOLOGOUS, FROM PERIPHERAL BLOOD, SELECTED BY CD62L EXPRESSION, EXPANDED AND TRANSDUCED (GENETICALLY MODIFIED) THROUGH A LENTIVIRAL VECTOR TO EXPRESS A CHIMERIC RECEPTOR WITH ANTI-CD19 SPECIFICITY ASSOCIATED WITH CO-STIMULATORY SEQUENCES 4-1-BB AND CD3Ζ IN PATIENTS WITH B-CELL NON-HODGKIN LYMPHOMA.
Trial Treatment · Phase 1/2 · Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau
Hospital de la Santa Creu i Sant Pau, Barcelona · University Hospital Virgen Del Rocio S.L., Sevilla
Registry updated 2025-09-29
NCT06363994
A Global Phase 3 Study of Orelabrutinib+BR Vs.BR in Pts with TN MCL
Trial Treatment · Phase 3 · InnoCare Pharma Inc.
Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital Universitario Reina Sofia, Córdoba · Hospital Universitario Infanta Leonor, Madrid · Hospital Universitario HM Sanchinarro, Madrid · Hospital Moncloa Grupo Hla S.A., Madrid · Hospital Universitario 12 de Octubre, Madrid · Hospital Beata María Ana, Madrid · MD Anderson Cancer Center, Madrid · Hospital Universitario Fundación Jiménez Díaz, Madrid · Hospital Universitario Virgen de la Victoria, Málaga · Hospital Quironsalud Malaga, Málaga · Clínica Universidad de navarra, Pamplona · Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcón · Complexo Hospitalario Universitario De Santiago, Santiago de Compostela · Hospital Universitario Virgen De La Macarena, Sevilla · Hospital Clinico Universitario de Valencia, Valencia
Registry updated 2024-12-27
NCT06482684
CAR-T-cell Treatment for Untreated High Risk MANtle Cell Lymphoma
Trial Treatment · Phase 2 · Christian Schmidt, MD
Hospital Clinic de Barcelona, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Institut Catala D'oncologia, L'Hospitalet de Llobregat · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario De Salamanca, Salamanca · University Hospital Virgen Del Rocio S.L., Sevilla · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2024-07-01

All Mantle cell lymphoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error